Medical Research News

RSS

Danish scientists have identified which head and neck cancer patients will benefit from additional drug treatment during radiotherapy

Tumours that have low concentrations of oxygen (hypoxia) are resistant to radiotherapy. A drug called nimorazole (a hypoxia radiosensitiser) can improve the outcome of radiotherapy for patients with these types of tumours. However, at the moment there is no way to identify people with tumours that lack oxygen, who need this additional drug treatment, from those that only need radiotherapy.

30 Aug 2005

Simple new way to modify collagen, paving the way for better infection-fighting bandages

Collagen often pops up in beauty products and supermodel lips. But by mating collagen with a molecular hitchhiker, materials scientists at Johns Hopkins hope to create some important medical advances.

30 Aug 2005

Ten years of mobile phone use shows no brain cancer link

According to researchers in the UK, there is no link between mobile phone use and brain cancer.

30 Aug 2005

Designer molecules that combine metals such as copper with natural organic materials could treat diseases in the body

That's the finding of chemists at Ohio State University, who have successfully tested such molecules against portions of HIV and Hepatitis C virus RNA in the laboratory. They've also created molecules that act like ACE, or angiotensin-converting enzyme, inhibitors - drugs that are used to lower blood pressure.

30 Aug 2005

Step towards understanding cell mutations that cause a variety of human diseases

A step towards understanding cell mutations that cause a variety of human diseases, particularly in children - including that which brings about premature aging and early death - has been taken by researchers at the Hebrew University of Jerusalem Silberman Institute of Life Sciences and the John Hopkins University School of Medicine.

30 Aug 2005

Toxicity from chemotherapy in lung cancer patients could help predict treatment efficacy

Chemotherapy is standard treatment for patients with advanced non-small cell lung cancer, although benefits are modest and toxicity substantial. Massimo Di Maio and colleagues hypothesised that neutropenia, a haematological toxicity, could be a predictor of drug activity and treatment efficacy.

30 Aug 2005

Unique Internet test to test genetic disposition to depression

The team, based at the Neuroscience and Psychiatry Unit (NPU), in the Faculty of Medical and Human Sciences, has set up a website (www.newmood.co.uk) where would-be volunteers can see how prone they may be to depression by identifying the emotions on people's faces and taking a gambling test.

From The University of Manchester 30 Aug 2005

Possibility of a continuously functioning, wearable or implantable artificial kidney

Researchers have developed a human nephron filter (HNF) that would eventually make possible a continuously functioning, wearable or implantable artificial kidney.

30 Aug 2005

Asian bird flu expert joins Murdoch University

Murdoch University's School of Veterinary and Biomedical Sciences have appointed Dr Trevor Ellis, an expert in Asian Bird flu, SARS and Foot and Mouth Disease.

30 Aug 2005

Viagra fights heart and lung diseases

German researchers have reported on the impact of Viagra on pulmonary hypertension at the Frontiers of Vascular Medicine Conference at Monash University this week.

30 Aug 2005

Scientists help narrow the search for BRCA1 carriers

Cancer Research UK scientists have identified a new test which may help narrow the search for breast cancer patients likely to carry the faulty BRCA1 gene.

30 Aug 2005

Australian National University facility to help reveal secrets of life

High technology that will enhance the ability of biologists to conduct cutting-edge research has been opened at the Research School of Biological Sciences (RSBS) at the Australian National University.

30 Aug 2005

Severely restricting calories over decades won't dramatically extend life span

Severely restricting calories over decades may add a few years to a human life span, but will not enable humans to live to 125 and beyond, as many have speculated, evolutionary biologists report.

30 Aug 2005

Daydreaming linked to Alzheimer's disease

According to new research, Alzheimer's disease may be due to abnormalities in the regions of the brain that operate the "default state", a term used to describe the cognitive state people defer to when musing, daydreaming, or thinking to themselves.

30 Aug 2005

New treatment can zap cancer cells and avoid healthy tissue

Australian researchers say they have developed a cancer treatment which can identify and kill individual cancer cells.

30 Aug 2005

Anti-cancer antibodies produced in chickens

A team of researchers have produced the first fully functional, human sequence monoclonal antibodies (mAbs) in chickens.

29 Aug 2005

Dental problems caused by radiation, chemotherapy should be treated before a child undergoes immunosuppression as part of bone marrow transplantation therapy

Many children who undergo bone marrow transplantation (BMT) as part of cancer treatment already have dental abnormalities that leave them vulnerable to potentially life-threatening bacterial infections, according to investigators at St. Jude Children's Research Hospital. A report on this study appears in the prepublication online edition of Bone Marrow Transplantation.

29 Aug 2005

Three-dimensional molecular structure of a promising malaria-vaccine component

An international team of scientists that includes a researcher from the U.S. Department of Energy's Brookhaven National Laboratory has determined the three-dimensional molecular structure of a promising malaria-vaccine component.

29 Aug 2005

Drugs known as farnesyltransferase inhibitors (FTIs) may hold promise for premature aging disorder

In a surprising development, a research team led by the National Human Genome Research Institute (NHGRI), has found that a class of experimental anti-cancer drugs also shows promise in laboratory studies for treating a fatal genetic disorder that causes premature aging.

29 Aug 2005

New tool to help unravel the function of an elusive DNA structure

A Rensselaer researcher has developed a new tool to help unravel the function of an elusive DNA structure. The findings, which were presented today at the 230th national meeting of the American Chemical Society (ACS) in Washington, D.C., could lead to a better understanding of diseases such as cancer and diabetes.

29 Aug 2005

Medical Research News

Danish scientists have identified which head and neck cancer patients will benefit from additional drug treatment during radiotherapy

Simple new way to modify collagen, paving the way for better infection-fighting bandages

Ten years of mobile phone use shows no brain cancer link

Designer molecules that combine metals such as copper with natural organic materials could treat diseases in the body

Step towards understanding cell mutations that cause a variety of human diseases

Toxicity from chemotherapy in lung cancer patients could help predict treatment efficacy

Unique Internet test to test genetic disposition to depression

Possibility of a continuously functioning, wearable or implantable artificial kidney

Asian bird flu expert joins Murdoch University

Viagra fights heart and lung diseases

Scientists help narrow the search for BRCA1 carriers

Australian National University facility to help reveal secrets of life

Severely restricting calories over decades won't dramatically extend life span

Daydreaming linked to Alzheimer's disease

New treatment can zap cancer cells and avoid healthy tissue

Anti-cancer antibodies produced in chickens

Dental problems caused by radiation, chemotherapy should be treated before a child undergoes immunosuppression as part of bone marrow transplantation therapy

Three-dimensional molecular structure of a promising malaria-vaccine component

Drugs known as farnesyltransferase inhibitors (FTIs) may hold promise for premature aging disorder

New tool to help unravel the function of an elusive DNA structure

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Latest News